One Case of Cushing's Syndrome Induced by Long-term Oral Dexamethasone Tablets

Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (6): 366-367.

Previous Articles Next Articles

One Case of Cushing's Syndrome Induced by Long-term Oral Dexamethasone Tablets

ZHUANG Hong-yan^1,2,3, XUE Chun-miao^4,*, XIAO Min⁴, CAO Jun-ling⁴, MAO Liu-ying⁴, ZHANG Sha-sha⁴, LIANG Yan

1 Dept.of Pharmaceutical Affairs, Beijing Anding Hospital, Capital Medical University, Beijing 100088,China;
2 The National Clinical Research Center for Mental Disorders, Beijing 100088, China;
3 Beijing Key Laboratory of Mental Disorders, Beijing 100088, China;
4 Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China

Received:2018-08-03 Revised:2018-08-03 Online:2018-06-15 Published:2018-08-03

Abstract

CLC Number:

R994.11

ZHUANG Hong-yan, XUE Chun-miao, XIAO Min, CAO Jun-ling, MAO Liu-ying, ZHANG Sha-sha, LIANG Yan. One Case of Cushing's Syndrome Induced by Long-term Oral Dexamethasone Tablets[J]. Chinese Journal of Pharmacovigilance, 2018, 15(6): 366-367.

References

[1] Bas V N, Cetinkaya S, Aycan Z.Iatrogenic Cushing Syndrome due to nasal steroid drops[J].Eur J Pediatr,2012,171(4):735-736.
[2] 林庆程,林强.临床X线读片诊断要诀[M].杭州:浙江科学技术出版社,2000:230-232.
[3] 沈周俊. 现代肾上腺外科诊疗学[M].上海:上海交通大学出版社,2015:75-77.
[4] 张永红. 神经外科常见疾病诊治指南及专家共识[M].兰州:兰州大学出版社,2016:198.
[5] Plotz C M, Knowlton A I, Ragan C.The natural history of cushing's syndrome[J].Am J Med,1952,13(5):597-614.
[6] Lindholm J, Juul S, Jorgensen J O, et al.Incidence and late prognosis of cushing's syndrome: a population-based study[J]. J Clin Endocrinol Metab, 2001, 86(1): 117-123.
[7] Dekkers O M, Horvath-Puho E, Jorgensen J O, et al.Multisystem morbidity and mortality in cushing's syndrome: a cohort study[J]. J Clin Endocrinol Metab, 2013, 98(6): 2277-2284.
[8] 冯铭,卢琳,陆召麟,等.美国库欣综合征治疗指南(2015版)解读[J].中华医学杂志,2016,96(31):2452-2453.
[9] 中华医学会内分泌学分会.库欣综合征专家共识(2011年)[J].中华内分泌代谢杂志,2012,28(2):96-102.
[10] 张茂姬,罗敏.醋酸泼尼松片和注射用氢化可的松琥珀酸钠致过敏反应1例[J].中国药物警戒,2017,14(4):255-256.
[11] Hopkins R L, Leinung M C.Exogenous Cushing's Syndrome and glucocorticoid with drawal[J]. Endocrinol Metab Clin North Am, 2005, 34(2):371-384.
[12] 国家药典委员会.临床用药须知[M].北京:中国医药科技出版社,2010:604-605.
[13] 茅伟安. 皮肤病用药速查手册[M]. 北京:金盾出版社,2014:274-275.
[14] 董宗祈. 糖皮质激素与促皮质激素的关系及应用[J].中国实用儿科杂志,2000,15(1):17-18.
[15] 卢琳,曾正陪.美国内分泌学会的临床指南:Cushing综合征的诊断[J].中华内分泌代谢杂志,2008,24(5):552-555.
[16] 中华医学内分泌学分会,Cushing综合征专家共识(2011年)[J].中华内分泌代谢杂志,2012,28(2):96-102.
[17] 丁国宪. 内分泌代谢性疾病临床处方手册[M].南京:江苏科学技术出版社,2015:112-114.
[18] 张庆柱. 药物治疗学[M].济南:山东大学出版社,2016:335-337.
[19] 陈莉,连加阵.地塞米松致不良反应2例[J].海军医学杂志,2007,28(3):288-289.
[20] 高玉霞,王瑞霞,伦冠芬,等.长程使用糖皮质激素患者的药学监护[J].中国医院药学杂志,2013,33(10):830-836.

One Case of Cushing's Syndrome Induced by Long-term Oral Dexamethasone Tablets

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131.
[2]	ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136.
[3]	BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140.
[4]	JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166.
[5]	LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180.
[6]	FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.
[7]	ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189.
[8]	WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194.
[9]	LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198.
[10]	XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203.
[11]	GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207.
[12]	FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210.
[13]	LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212.
[14]	CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218.
[15]	ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222.